APA (7th ed.) Citation

Hajda, J., Lehmann, M., Kieser, M., Jäger, D., Schöning, T., Sedlaczek, O., . . . Springfeld, C. (2017). A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol. BioMed Central; Springer. https://doi.org/10.1186/s12885-017-3604-y

Chicago Style (17th ed.) Citation

Hajda, Jacek, et al. A Non-controlled, Single Arm, Open Label, Phase II Study of Intravenous and Intratumoral Administration of ParvOryx in Patients with Metastatic, Inoperable Pancreatic Cancer: ParvOryx02 Protocol. London; Berlin; Heidelberg: BioMed Central; Springer, 2017. https://doi.org/10.1186/s12885-017-3604-y.

MLA (9th ed.) Citation

Hajda, Jacek, et al. A Non-controlled, Single Arm, Open Label, Phase II Study of Intravenous and Intratumoral Administration of ParvOryx in Patients with Metastatic, Inoperable Pancreatic Cancer: ParvOryx02 Protocol. BioMed Central; Springer, 2017. https://doi.org/10.1186/s12885-017-3604-y.